Clinical Trials
Immunochina will endeavor and provide the high-quality service to
assist each patient to fight cancer. We sincerely wish all patients a speedy and sound recovery
Imunopharm Technology Co., Ltd. is currently conducting various CAR-T clinical trials for relapsed or refractory non-Hodgkin's lymphoma, multiple myeloma, liver cancer and pancreatic cancer. If you are interested in participation, please contact Mr. Wu at 010-62886890.
| Drug | Disease | Subject's Description |
| IM19 | relapsed or refractory non-Hodgkin's lymphoma | If you or your acquaintances are suffering from relapsed or refractory non-Hodgkin's lymphoma, and are over 18 years old, feel free to contact us. We will evaluate your situation and let you know if you are suitable for the IM19 therapy. |
If you would like more information, please contact us through the following ways：
Phone:010-62886890
Web: http://www.imunopharm.com
Email: wufei@imunopharm.com
